MedTrace Logo

Trial of Clindamycin / Benzoyl Peroxide Gel in Subjects With Acne

NCT00776919 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 1315

Last updated 2016-11-23

Study results available
· View outcomes & findings →

Summary

This is a Randomized, Double-Blind, Controlled Study to evaluate the Safety and Efficacy of a clindamycin / benzoyl peroxide gel in Subjects with Acne Vulgaris

Conditions

  • Acne Vulgaris

Interventions

DRUG

clindamycin / benzoyl peroxide gel

Once a day application to the face

DRUG

clindamycin gel

Once a day application to the face

DRUG

BPO gel

Once a day application to the face

DRUG

vehicle gel

Once a day application to the face

Sponsors & Collaborators

  • Rho, Inc.

    collaborator INDUSTRY

  • Quintiles, Inc.

    collaborator INDUSTRY

  • GlaxoSmithKline

    collaborator INDUSTRY

  • Stiefel, a GSK Company

    lead INDUSTRY

Principal Investigators

  • GSK Clinical Trials · GlaxoSmithKline

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
12 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-10-31
Primary Completion
2009-09-30
Completion
2009-09-30

Countries

  • United States
  • Belize
  • Canada

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00776919 on ClinicalTrials.gov